aim aim study evaluate previously observed changes fatty acid profile result dha supplementation maintained longer study trials observe effect clinical outcome cystic fibrosis cf patients method doubleblind study performed deltaf508 homozygous cf patients age NUMBER clinical data including pulmonary function number infections collected blood determination fatty acid fa composition serum phospholipid vitamin e liver enzymes immunoglobulins erythrocyte sedimentation rate coagulation drawn beginning NUMBER months start study results seventeen patients included dropped treatment group supplemented algal oil control group sunflower seed oil difference control treatment groups caloric intake fev1 fvc start study NUMBER year supplements phospholipid fa composition did change control group treatment group significant increase dha eicosapentaenoic acid epa concentration concomitant decrease acid arachidonic acid NUMBER mead acid observed laboratory results showed changes vitamin e level liver enzymes albumin erythrocyte sedimentation rate igg concentration placebo intervention group conclusion oil shifted serum phospholipid fas profile conclusive clinical improvement observed far year long placebo controlled dha rich dihomo gammalinolenic n NUMBER dha rich pro inflammatory w h